Vexim SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Edison Investment Research
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Vexim SA Accelerates European Development and Establishes Subsidiary in Spain
Vexim SA announced the establishment of a new subsidiary, Vexim Spine SL in Spain (Barcelona) that will enable the Company to accelerate the commercialization of the SpineJack range in this territory.
Latest Developments for Vexim SA
- Vexim SA obtains FDA approval to market masterflowTM injection system in the United States
- Vexim announces launch of private placement for about 5 million euros
- Vexim to commence U.S. sales and marketing operations with appointment of regional sales director
- Vexim announces positive preliminary results of Spinejack and Medtronic balloon comparison
- Share this
- Digg this